Replay available

MaxCyte, Inc. (MXCT) Q2 2026 Earnings Call

MaxCyte, Inc. (NASDAQ: MXCT) Q2 2026 earnings conference call, held 2026-08-12. Replay captured from the company's public earnings webcast.

Wed, August 12, 2026 at 4:30 PMendedReplay
MaxCyte, Inc. (MXCT) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Eric Abdel

Investor Relations

Maher Masoud

President and Chief Executive Officer

Parmeet Ahuja

Chief Financial Officer

Julie Simmons

Analyst, PaymentWord Liberal

Hannah Rayford

Analyst, Stevens Inc.

Matt Hewitt

Analyst, Greyhound Capital Group

Dan Arias

Analyst, State Forward

Brandon Smith

Analyst, T-Con

Replay transcript excerpt

Good day. Thank you for standing by. Welcome to the MaxCyte Second Quarter Earnings Conference Call. At this time, all participants are in listen-only mode. After this speaker's presentation, there will be a question and answer session. To ask the question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message device when your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Eric Abdel of Investor Relations. Please go ahead. Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from MacCyte, we have Maher Masoud, President and Chief Executive Officer, Parmeet Ahuja, Chief Financial Officer, and Sean Menorquez, Senior Director of Business Development. Earlier today, MacCyte released financial results for the second quarter ended June 30, 2026. A copy of the press release is available on the company's website. Before we begin, I need to read the following statement. Statement or comments made during this call may be forward-looking statements within the meaning of federal securities laws. Any statements contained in this call, other than statements of historical fact, including those that relate to expectations or predictions of future events, results, or performance, are forward-looking statements. Actual results may differ materially from those expressed or implied in any forward-looking statements due to a variety of factors which are discussed in detail in our SEC filings. Acceptance required by applicable law. The company has no obligation to publicly update any forward-looking statements, whether becaus...

More from Maxcyte, Inc.